BackVirax Biolabs Group Overview

Virax Biolabs Group Receivables

Virax Biolabs Group's receivables is $0.

Get informed when a big investor buys or sells

+ Follow
Receivables
$0.00
↓ 100.00% YoYΔ $-30654.00 vs prior year quarter

Peer average

Loading

Virax Biolabs Group Receivables History

Loading

Virax Biolabs Group vs. peers: Receivables Comparison

Loading

Virax Biolabs Group Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Virax Biolabs Group (VRAX) FAQ

Virax Biolabs Group (VRAX) currently reports a receivables of $0 as of March 2026. That compares with $31K in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Virax Biolabs Group's receivables history and peer comparisons.

Virax Biolabs Group's receivables decreased from $31K to $0 — a 100.0% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Virax Biolabs Group reported $0 in receivables as of March 2026. That compares with $31K in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Virax Biolabs Group, and consider following VRAX for alerts when major investors trade the stock.